Skip to main content
Log in
Register
Home
our Medicines
Pipeline
Contact
MENU
Home
Search
Our Medicines
Pipeline
Search Clinical Trials
Select Interventions
Cenobamate (Xcopri; YKP3089)
Carisbamate (YKP509; RWJ-333369)
SKL24741
YKP10811
SKL15508
SKL11197
SKL27969
I affirm that this query is unsolicited.
Search Results :
31
Select Status
Any
Not recruiting
Active
Recruiting
Completed
Approved for marketing
Enrolling by invitation
Terminated
Not Yet Recruiting
1
25
50
100
All
Title
(Conditions)
Interventions
Status
Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy
(Focal Onset Seizure)
Cenobamate
Active, Not Recruiting
Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures
(Partial Epilepsy)
Xcopri
Active, Not Recruiting
Cenobamate Expanded Access Program (EAP)
(Partial Epilepsy)
YKP3089
Approved For Marketing
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
(Partial Epilepsy)
YKP3089
Completed
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
(Chronic Idiopathic Constipation)
YKP10811
Completed
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy
(Painful Diabetic Neuropathy)
SKL11197
Completed
A Proof of Concept Study of the Effectiveness of Carisbamate in the Treatment of Essential Tremor
(Essential Tremor, Movement Disorders)
Carisbamate
Completed
A Randomized, Open-label, Three-way Crossover Study to Evaluate the Relative Bioavailability of 200 Mg Cenobamate Administered Orally
(Healthy Volunteers)
Cenobamate
Completed
A Safety, Tolerability, PK and PD Study of Multiple Oral Doses of SKL15508 in Subjects With Stable Schizophrenia
(Schizophrenia)
SKL15508
Completed
A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures.
(Epilepsy, Partial, Motor)
Carisbamate
Completed
A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.
(Epilepsy)
RWJ-333369
Completed
A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.
(Epilepsy)
RWJ-333369
Completed
A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine
(Migraine Headaches)
RWJ-333369
Completed
Assess the Influence of Cenobamate on the PK of Cytochrome P450 (CYP) Probe Drugs As a Means of Predicting Drug-drug Interactions
(Healthy)
Cenobamate
Completed
Bioavailability and Food Effect Study of 3 Types of Carisbamate
(Healthy Subjects)
Carisbamate
Completed
Carisbamate Safety Study in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome
(Lennox Gastaut Syndrome)
Carisbamate
Completed
Carisbamate in Adult & Pediatric Subjects With Lennox-Gastaut Syndrome
(Lennox Gastaut Syndrome)
Carisbamate
Completed
Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures
(Partial Epilepsy)
Xcopri
Completed
Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures
(Partial Epilepsy)
YKP3089
Completed
Efficacy of YKP3089 in Patients With Photosensitive Epilepsy
(Epilepsy)
YKP3089
Completed
Long Term Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures
(Seizures)
RWJ-333369
Completed
Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures
(Primary Generalized Epilepsy)
Cenobamate
Completed
Safety Study of Cenobamate in Subjects With Normal Hepatic Function and Subjects With Severe Hepatic Impairment
(Hepatic Impairment)
Cenobamate
Completed
Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy
(Refractory Epilepsy)
RWJ-333369
Completed
Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
(Partial Epilepsy)
YKP3089
Completed
Single-Dose Escalation Study Followed by a Multiple-Dose Escalation Study of SKL24741 in Healthy Subjects
(Healthy)
SKL24741
Completed
Cenobamate Open-Label Extension Study for YKP3089C025
(Primary Generalized Tonic Clonic Seizures in the Setting of Idiopathic Generalized Epilepsy)
Cenobamate
Enrolling By Invitation
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
(Seizures)
Carisbamate
Recruiting
Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures
(Seizures)
RWJ-333369
Terminated
Safety, Tolerability, PK/PD & Preliminary Efficacy of SKL27969 in Advanced Solid Tumors Patients
(Advanced Solid Tumor)
SKL27969
Terminated
Randomized, Double-blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in POS
(Partial Seizure)
Cenobamate
Unknown
1
25
50
100
All